← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Funds holding	Growth	Growth %	Fund value
51	51 Cellectis CLLS $113M	–	–	–	–
52	52 Coya Therapeutics COYA $98.1M	–	–	–	–
53	53 Caribou Biosciences CRBU $49.3M	–	–	–	–
54	54 DELISTED CARGO Therapeutics CRGX	–	–	–	–
55	55 CRISPR Therapeutics CRSP $4.86B	–	–	–	–
56	56 DELISTED CATALENT, INC. CTLT	–	–	–	–
57	CYAD 57 DELISTED Celyad Oncology SA American Depositary Shares CYAD	–	–	–	–
58	DBTX 58 DELISTED Decibel Therapeutics, Inc. Common Stock DBTX	–	–	–	–
59	59 Precision BioSciences DTIL $166M	–	–	–	–
60	60 enGene Therapeutics ENGN $105M	–	–	–	–
61	61 Enlivex Ltd ENLV $4.29M	–	–	–	–
62	62 Estrella Immunopharma ESLA $13.8M	–	–	–	–
63	63 FibroBiologics FBLG $6.73M	–	–	–	–
64	64 4D Molecular Therapeutics FDMT $674M	–	–	–	–
65	FRLN 65 DELISTED Freeline Therapeutics Holdings plc American Depositary Shares FRLN	–	–	–	–
66	66 DELISTED Generation Bio GBIO	–	–	–	–
67	67 CytoMed Therapeutics GDTC $10.3M	–	–	–	–
68	GMDA 68 DELISTED Gamida Cell Ltd. Ordinary Shares GMDA	–	–	–	–
69	69 Genprex GNPX $1.91M	–	–	–	–
70	70 Genenta Science GNTA $31.8M	–	–	–	–
71	GRCL 71 DELISTED Gracell Biotechnologies Inc. American Depositary Shares GRCL	–	–	–	–
72	GRML 72 Greenland Mines Ltd GRML $86.6M	–	–	–	–
73	73 Fractyl Health GUTS $54.1M	–	–	–	–
74	74 Immix Biopharma IMMX $706M	–	–	–	–
75	75 Immatics IMTX $1.07B	–	–	–	–